Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Business Insights | Immunomodulators - Therapeutic Needs, Pipelines & Prospects

Immunomodulators - Therapeutic Needs, Pipelines & Prospects

The modulation of immune system activity is a required pharmacological intervention for many medical conditions, bearing particular importance in the treatment of autoimmune diseases and allergies and transplant procedures. With traditional immunomodulatory drugs continuing to exhibit limited efficacy and adverse side effects, the drive to develop new, improved, and specifically targeted immunotherapies has been gaining momentum. ‘Immunomodulators: Therapeutic Needs, Pipelines & Prospects’ is a new report published by Business Insights that provides a detailed examination of the current market for immunomodulatory therapies. The strategies and technologies used in immunomodulation are analysed and the major clinical applications of immunomodulators are reviewed to identify the leading drug classes and most promising agents currently in development. This report will also investigate patient metrics and provide market forecasts for immunomodulators to 2011.

Pages 345 August 2007 Foramat PDF
Table of Contents
Price: $2,875.00 / €1,923.38

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions